BU-NOT-SET

CONTACT US
Developing a high throughput screening method
  • Drug substance
Eyes
Insight
Why outsourcing is key to bringing flexibility and capacity to the manufacture of oral solid dosage forms
  • Manufacturing
Eyes
Insight
Can bigger be better?
  • Industry trends
Eyes
Insight
What does 2017 have in store for the pharma industry?
  • Industry trends
Eyes
Insight
Reflecting on 2017 | the factors shaping our industry
  • Industry trends
Eyes
Insight
Protecting against counterfeiting with serialisation
  • Manufacturing
Eyes
Insight
Manufacturing Chemist CDMO roundtable – part two
  • Industry trends
Eyes
Insight
Manufacturing Chemist CDMO roundtable – part one
  • Industry trends
Eyes
Insight
Increased drive to outsource manufacturing in life science
  • Industry trends
  • Manufacturing
Eyes
Insight
Poster
  • Drug substance
Innovative ALS Tablet Development
Insight
  • Drug product
  • Manufacturing
How Blow-fill-seal (BFS) technology may be a superior alternative to glass vials during the early stages of a development project
White paper
  • Biologics
Product Quality in the Advanced Therapies Manufacturing
Insight
  • Biologics
Navigating ATMP fill and finish complexities
Insight
  • Biologics
The power of analytics and AI in the era of continuous RNA manufacturing
Insight
  • Biologics
Reimagining the RNA manufacturing space: An interview with ReciBioPharm’s leaders
Insight
  • Biologics
Unlocking the potential of mRNA: Inside ReciBioPharm's Watertown site
Insight
  • Biologics
Industry 5.0 in action: AI-driven continuous manufacturing for RNA therapeutics
Insight
  • Drug product
  • Manufacturing
Choosing the optimal container format for sterile drug products